Annual Report And Accounts

Overview

The report highlights continued progress in Device Authority, FundamentalVR and Talking Medicines, alongside five new SVV2 investments during 2024. It describes an ESG Committee, PRI-aligned investment screening and quarterly ESG workshops, as well as reduced air travel. Financially, the report states that net assets at 31 December 2024 were £10.7m.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2024
Period: Ends 31 December 2024
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services